Autoregulation of Cerebral Blood Flow
脑血流的自动调节
基本信息
- 批准号:8236714
- 负责人:
- 金额:$ 63.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-05 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimal ModelApplications GrantsBackcrossingsBase PairingBiological ModelsBlood VesselsBlood flowBreedingCandidate Disease GeneCerebrovascular CirculationCerebrumChromosomesChromosomes, Human, Pair 1CodeCongenic AnimalsCongenic StrainDataDiseaseEventExhibitsFigs - dietaryFutureGenerationsGenesGeneticGenetic ModelsGenetic PolymorphismGenotypeGrantHomeostasisHumanHydroxyeicosatetraenoic AcidsKnockout MiceKnowledgeLeftLinkLiteratureMAP Kinase GeneMaintenanceMediatingMembraneMethodologyModelingMuscleMutateNaturePhenotypePlayPropertyProtein Tyrosine KinaseProtein phosphataseProteinsProtocols documentationQuantitative Trait LociRat StrainsRattusRattus norvegicusRecoveryRegulationReportingRho-associated kinaseRoleSignal PathwaySignal TransductionSignaling MoleculeSiteSmall Interfering RNASpecificityStretchingStrokeTRP channelTechniquesTraumatic Brain InjuryWorkadducinaging populationbasecomparativecongenicconsomicconstrictiondesigngenetic linkageinterestknock-downlarge-conductance calcium-activated potassium channelsoffspringpressureresearch studyresponserestorationtool
项目摘要
DESCRIPTION (provided by applicant): There exists a substantial amount of literature regarding the cellular and ionic mechanisms responsible for pressure-induced myogenic regulation of cerebral blood flow (CBF) autoregulation. However, our understanding of the mechanisms by which pressure activates myogenic tone in the arterial wall is only poorly understood. We describe in this application an animal model in which one rat strain, the Fawn Hooded rat (FHH) does not auto regulate CBF in the face of an increasing arterial pressure, whereas, years of consomic interbreeding of 9 generation breeding we found that transfer of a region on chromosome 1 of a Brown Norway (BN) rat recovered the myogenic phenotype in the FHH.1BN consomic rat. It became clear that a locus on chromosome 1 contained a gene coding for the trigger of myogenic tone in response to changes in arterial pressure. 3-5 years of selective manipulation of chromosome 1 and phenotyping F1 generations of interbred offspring have narrowed the region of this chromosome to a 1.2 M base pair quantitative trait loci (QTL) containing the gene for adducin3 (Add3) and DUSP-5 along with other incomplete genes. Transfer of this 1.2 M base QTL confers a normal auto regulatory phenotype in the FHH rat. Using siRNA methodology to knockdown Add3 and DUSP-5 we have, in preliminary experiments, significantly reduced auto regulatory capacity by knocking down Add3 and DUSP-5 protein levels. Protocols described in this application are designed to define the cellular signaling cascades responsible for the actions of Add3, DUSP-5 or other yet unidentified genes in this 1.2 M base QTL. Similarly, we will identify the ionic species responsible for pressure-induced membrane depolarization which is necessary for initiation and maintenance of pressure-induced myogenic tone. These rat strains are the congenic animal model allowing identification of the mechanisms responsible for pressure-induced autoregulation in which no compensatory changes in the background genotype can occur, unlike that which can occur in a knockout mouse.
PUBLIC HEALTH RELEVANCE: The proposed work using the genetic model of rat described in the grant application will aid us in identifying signaling events and ionic mechanisms that controls the myogenic tone and the autoregulation of cerebral blood flow. This information will help in developing better future treatment options for neurovascular related diseases such as stroke, traumatic brain injury, dementia and Alzheimers in aging population of humans.
描述(由申请人提供):存在大量关于负责脑血流(CBF)自动调节的压力诱导的肌原性调节的细胞和离子机制的文献。然而,我们对压力激活动脉壁生肌张力的机制了解甚少。我们在本申请中描述了一种动物模型,其中一种大鼠品系,小鹿连帽大鼠(FHH)在面临动脉压增加时不会自动调节CBF,而经过多年的9代同体杂交,我们发现棕色挪威(BN)大鼠1号染色体上的一个区域的转移恢复了FHH.1BN同体大鼠的肌源表型。很明显,1 号染色体上的一个基因座含有一个基因,该基因编码可触发肌源性张力,以响应动脉压的变化。对 1 号染色体进行 3-5 年的选择性操作并对杂交后代的 F1 代进行表型分析,已将该染色体的区域缩小到 1.2 M 碱基对数量性状位点 (QTL),其中包含内收蛋白 3 (Add3) 和 DUSP-5 基因以及其他不完整基因。该 1.2 M 碱基 QTL 的转移赋予 FHH 大鼠正常的自动调节表型。在初步实验中,我们使用 siRNA 方法敲低 Add3 和 DUSP-5,通过敲低 Add3 和 DUSP-5 蛋白水平,显着降低了自动调节能力。本申请中描述的方案旨在定义负责此 1.2 M 碱基 QTL 中 Add3、DUSP-5 或其他尚未鉴定的基因的作用的细胞信号级联。同样,我们将确定负责压力诱导膜去极化的离子种类,这对于压力诱导肌原性张力的启动和维持是必要的。这些大鼠品系是同类动物模型,可以鉴定负责压力诱导的自动调节的机制,其中背景基因型不会发生补偿性变化,这与基因敲除小鼠中可能发生的情况不同。
公共健康相关性:拟议的使用拨款申请中描述的大鼠遗传模型的工作将帮助我们识别控制肌源张力和脑血流自动调节的信号事件和离子机制。这些信息将有助于为老年人口中的神经血管相关疾病(如中风、创伤性脑损伤、痴呆和阿尔茨海默病)开发更好的未来治疗方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Rae Harder其他文献
David Rae Harder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Rae Harder', 18)}}的其他基金
Modification of Vascular Signaling in the Brain by ROS
ROS 改变大脑血管信号传导
- 批准号:
7582973 - 财政年份:2009
- 资助金额:
$ 63.57万 - 项目类别:
Modification of Vascular Signaling in the Brain by ROS
ROS 改变大脑血管信号传导
- 批准号:
8009430 - 财政年份:2009
- 资助金额:
$ 63.57万 - 项目类别:
Modification of Vascular Signaling in the Brain by ROS
ROS 改变大脑血管信号传导
- 批准号:
8206555 - 财政年份:2009
- 资助金额:
$ 63.57万 - 项目类别:
Modification of Vascular Signaling in the Brain by ROS
ROS 改变大脑血管信号传导
- 批准号:
8399039 - 财政年份:2009
- 资助金额:
$ 63.57万 - 项目类别:
Modification of Vascular Signaling in the Brain by ROS
ROS 改变大脑血管信号传导
- 批准号:
7751216 - 财政年份:2009
- 资助金额:
$ 63.57万 - 项目类别:
BIOCHEMICAL AND MOLECULAR BIOLOGY CORE LABORATORY
生化与分子生物学核心实验室
- 批准号:
7600722 - 财政年份:2008
- 资助金额:
$ 63.57万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 63.57万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 63.57万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 63.57万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 63.57万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 63.57万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 63.57万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 63.57万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 63.57万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 63.57万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 63.57万 - 项目类别:














{{item.name}}会员




